LVEF has proved to be a reliable parameter to the clinician contemplating the prognosis and management of patients with heart disease (e.g., in selecting patients for implantable cardioverter-defibrillators).
Over the past several decades, it has become established that performance measurements at different loading conditions or oxygen demand are preferable to those obtained at rest (2) . However, the simplicity of parameters such as LVEF have proved to be sufficient for most clinical needs. LGE with reduced GCS in patients with LVEF $35%
was prognostically similar to that in patients with LVEF <35%.
The authors performed CMR tagging using commercial software now available for all major CMR vendors and analyzed the data using harmonic phase imaging, a method developed and validated a decade ago (9) and that has been applied to clinical and largescale population studies (10, 11) . This is the first study establishing the prognostic significance of reduced GCS in a large-scale cohort of patients being investigated for cardiac structural and functional impairment. GCS across the left ventricle can be easily analyzed by CMR. Large datasets with reference values (12) exist for this technique, including that in the present study (8) . The results of the present study, as well as those from previous studies using CMR tagging (6) and echocardiography (7), suggest that regional function defined by strain may be more sensitive than ejection fraction in the detection of incipient myocardial dysfunction.
The authors utilized standard statistical methodology to assess the incremental prognostic value of distinct CMR parameters added to clinical indicators.
They also used a combined model to evaluate the added value of specific CMR indices over and above other CMR parameters, as demonstrated in Table 6 (8 Study on Atherosclerosis who were healthy at study entry, strain deficits predicted prognosis over and above LVEF (6) . The current study is a crucial step toward bringing such knowledge to application where it matters most, that is, patients with suspected heart disease.
